Trends in Molecular Medicine

Papers
(The H4-Index of Trends in Molecular Medicine is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives415
Permeability of the Endothelial Barrier: Identifying and Reconciling Controversies251
Tailoring mRNA Vaccine to Balance Innate/Adaptive Immune Response193
Glymphatic System Impairment in Alzheimer’s Disease and Idiopathic Normal Pressure Hydrocephalus190
G-quadruplex, Friend or Foe: The Role of the G-quartet in Anticancer Strategies174
Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies163
Impact of the Natural Compound Urolithin A on Health, Disease, and Aging156
Oxidative Stress and Redox-Modulating Therapeutics in Inflammatory Bowel Disease153
Cell-Free DNA and Apoptosis: How Dead Cells Inform About the Living138
Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome134
Nrf2: Redox and Metabolic Regulator of Stem Cell State and Function129
Ferroptosis in the tumor microenvironment: perspectives for immunotherapy123
The Gut Microbiota: Emerging Evidence in Autoimmune Diseases114
Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA114
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis99
Reducing Senescent Cell Burden in Aging and Disease97
Adult Hippocampal Neurogenesis in Major Depressive Disorder and Alzheimer’s Disease91
Cell-to-Cell Transmission of Tau and α-Synuclein87
Crosstalk between Sertoli and Germ Cells in Male Fertility85
Metabolic Pathways That Control Skin Homeostasis and Inflammation84
Targeting Ferroptosis: New Hope for As-Yet-Incurable Diseases78
Enhancers in disease: molecular basis and emerging treatment strategies74
Vitamins for the Gut Microbiome68
Ferroptosis in Parkinson’s disease: glia–neuron crosstalk68
Antibiotic Resistance by Enzymatic Modification of Antibiotic Targets64
Skin senescence: mechanisms and impact on whole-body aging64
COVID-19 in pregnancy: implications for fetal brain development63
Microbiota and sleep: awakening the gut feeling62
NIRF Nanoprobes for Cancer Molecular Imaging: Approaching Clinic62
Extracellular matrix-based cancer targeting61
Transcription Factor Inhibition: Lessons Learned and Emerging Targets61
Missing Pieces to the Endocannabinoid Puzzle59
NMDARs in Cell Survival and Death: Implications in Stroke Pathogenesis and Treatment56
Fertility Preservation: The Challenge of Freezing and Transplanting Ovarian Tissue55
Haptoglobin Therapeutics and Compartmentalization of Cell-Free Hemoglobin Toxicity55
The gut vascular barrier: a new player in the gut–liver–brain axis54
Crosstalk between bile acid-activated receptors and microbiome in entero-hepatic inflammation54
Therapeutic Manipulation of mtDNA Heteroplasmy: A Shifting Perspective49
Bacterial Peptidoglycan as a Driver of Chronic Brain Inflammation48
Preimplantation Genetic Testing for Aneuploidy – a Castle Built on Sand48
Activity-Based Diagnostics: An Emerging Paradigm for Disease Detection and Monitoring47
Fibroblast Heterogeneity in Wound Healing: Hurdles to Clinical Translation47
HDL and Reverse Remnant-Cholesterol Transport (RRT): Relevance to Cardiovascular Disease46
Lipid Nanoparticle-Mediated Delivery of mRNA Therapeutics and Vaccines45
Mouth-Watering Results: Clinical Need, Current Approaches, and Future Directions for Salivary Gland Regeneration44
0.086507081985474